Is High Health Spending Justified?


An international analysis has found that the higher cost of cancer care delivery in the United States appears to be worthwhile. The greater survival gains experienced by cancer patients generated $598 billion of additional value for those diagnosed between 1983 and 1999. The value of this additional survival was highest for prostate and breast cancer patients.

Abstract: Health Affairs, April 2012.

Submit a Comment

Your email address will not be published. Required fields are marked *

nineteen − 3 =